Lipoprotein(a) and heart risk in stage 4 kidney disease
Part of Heart & circulation clinical trials.
This study looks at whether a fat in your blood called lipoprotein(a) can help predict heart problems in people with stage 4 kidney disease. By tracking your health over 18 months, doctors hope to find better ways to protect your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have stage 4 chronic kidney disease and be under care at the Nîmes University Hospital.
- You are not currently on dialysis or have not had a kidney transplant.
- You must be able to come for check-ups over 18 months.
- You cannot have familial hypercholesterolemia or severe obesity (BMI over 40).
- You must not be participating in another interventional research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at the link between kidney disease and heart disease. It aims to understand how heart problems affect people with chronic kidney disease. The trial does not test a new drug, but rather follows patients to learn more about their health.
This study tests a new approach to protect the heart and kidneys in people with both chronic kidney disease and heart or blood vessel problems. By optimising treatment, researchers hope to reduce the risk of further kidney or heart damage.
This trial tests whether taking a moderate-strength statin (cholesterol-lowering drug) plus ezetimibe (another cholesterol medicine) together helps protect the heart and kidneys in people who have both chronic kidney disease and established heart disease or stroke history.
This study looks for new markers in blood or urine that may help explain heart (cardiovascular) risk in people with chronic kidney disease. It may help doctors better predict risk, especially in those not yet on dialysis.
This study looks at how well we can predict heart and kidney problems in people who have both coronary heart disease and chronic kidney disease. By analyzing certain markers, researchers hope to create a better risk assessment tool.
This study looks at new heart health tests for people with kidney disease. It may help doctors better understand heart risks and improve care.
Hear when a new CKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.